Can you imagine a cancer drug doing this across a range of stage IV cancers? Amazing long-term results from SABR-COMET. Congratulations to @drdavidpalma & colleagues. Modern radiation therapy is transforming cancer care #Radonc
Bon. Je ne suis pas virologue. Mais je suis médecin. Que penser de l’étude hydroxychloroquine (HCQ) de Raoult quand on n’est pas expert ? Eh bien, on garde les bons réflexes devant une étude à problèmes : on cherche ailleurs. Thread.
Thank you #EDFPulse and @RamsaySante for this video showing AI on the cancer battle field alongside great doctors and clinicians : Dr Levy and @adrienpaix , from IRHE Bobigny, one of the first centers who implemented @Therapanacea AI -solutions.
À #Bobigny, les radiothérapeutes - Dr @adrienpaix et Dr Hosni Popotte - rendent possible la prise en charge d’un plus grand nombre de patients au sein du département.
#radiothérapie
https://t.co/UDs60p2aVY
@DrewMoghanaki@samsonpp I would like to highlight that a "dominant" strategy mean that this strategy appears to be cheaper while giving more QALY. And the results reported are valid only in a French payer perspective. We will release an app that will allow you to run this model with your country costs.
What a great day for #pancsm and #radonc at #asco18. PREOPANC-1 : still a place for #radiotherapy in preoperative setting : Twice more R0 resection after irradiation vs upfront surgery. waiting for final analysis Next : neoadj mFOLFIRINOX --> #sbrt --> Surgery. https://t.co/QfJWmBXqCB